研究的主要终点是无进展生存期(progression-free survival),同时将对患者随访以观察整体存活率。该项研究将在美国、欧… www.bioon.com|基于41个网页 2. 无恶化存活期 无恶化存活期(progression-free survival),且其接受化疗所引起之嗜中性白血球减少 症的发生率,显著低於未接受MB-6合并治 … ...
progression free survival释义 常用 牛津词典 释义 无进展生存率;双语例句 全部 1. Results: The 5 - year overall and progression - free survival rates for 100 % and % , respectively. 结果: 五年的整体存活率及无疾病进展存活率分别为100%及%. 来自互联网 2. Progression free survival and response ...
overall survivalprogression‐free survivalquality of lifesurrogate end‐pointOverall survival (OS) is the undisputed gold standard efficacy endpoint in cancer drug trials. It is with growing concern that we observe how progression‐free survival (PFS) gains ground as surrogate endpoint in its place. ...
所有的肿瘤项目,都会用到PFS。PFS规则复杂,删失情况多。刚刚接触这部分,往往是既不理解为什么要做这么复杂,也不知道怎么把逻辑简化,导致代码又乱又长。 所有的TTE(time-to-event)分析,都是判断起点和终点。 起点:随机日期(单臂试验首次用药日期) 终点:肿瘤进展(PD)日期或死亡日期中的较早者。 PFS表示的是维持病...
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars PartnersPublications Resources Consensus ViewpointsInteractive ToolsSponsored Biomarker ConsortiumSubscribe Choose Specialty Biosimilars Brain Cancer ...
1.This study aims to analyze the factors that influence theprogression-free survival timeof PCa patients after endocrine therapy in an attempt to improve the prognosis of the disease.目的:前列腺癌内分泌治疗后发现进展速度存在较大差异,为了改善其预后,本文探讨前列腺癌内分泌治疗后无进展生存期的影响因素...
7.1The importance of antitumor immunity in long-term, progression-free survival Long-term survival of the patient is considered the “gold standard” of success in cancer treatment, but, from the patients' perspective, disease-free survival is the ultimate goal. In practice, using disease-free...
“PFS是Progression-Free-Survival的缩写,中文意思就是无进展生存时间,所代表的就是癌症患者从开始接受治疗,到出现疾病进展情况或者是因为各种原因出现死亡的这段时间,是现在临床上用于判断恶性肿瘤患者生存情况的重要指标,PFS时间越长就表示患者生存周期越长,时间短则表示生存周期短。
PFS 无进展生存期(progression-free survival) rPFS放射影像学无进展生存率 DCR 疾病控制率(disease control rate) ORR 客观缓解率(Objective Response Rate) OR 总缓解率 (overall response 或者 overall remission) PD 疾病进展(progression disease) MTD 最大耐受剂量(maximum tolerated dose) ...
Progression-free survival (PFS) in oncology: caveat emptor!PROGRESSION-free survivalCANCER chemotherapyONCOLOGYdoi:10.1111/bcpt.13192Sarac, Sinan B.Ainsworth, Mark A.Hovgaard, DorisBjerrum, Ole W.John Wiley and SonsBasic & Clinical Pharmacology & Toxicology...